REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 71 filers reported holding REVANCE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.63 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,423,531 | -53.1% | 385,661 | +3.5% | 0.00% | -50.0% |
| Q2 2023 | $9,428,203 | -5.4% | 372,509 | +20.4% | 0.00% | 0.0% |
| Q1 2023 | $9,965,097 | +72.6% | 309,379 | -1.1% | 0.00% | +100.0% |
| Q4 2022 | $5,772,350 | -30.8% | 312,695 | +1.1% | 0.00% | -50.0% |
| Q3 2022 | $8,347,000 | +133.2% | 309,162 | +19.4% | 0.00% | +100.0% |
| Q2 2022 | $3,579,000 | -33.2% | 258,964 | -5.7% | 0.00% | 0.0% |
| Q1 2022 | $5,354,000 | +18.8% | 274,539 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $4,508,000 | -40.2% | 276,244 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $7,538,000 | +1.4% | 270,553 | +7.9% | 0.00% | 0.0% |
| Q2 2021 | $7,433,000 | -29.4% | 250,778 | -33.4% | 0.00% | -50.0% |
| Q1 2021 | $10,525,000 | +3.8% | 376,598 | +5.2% | 0.00% | 0.0% |
| Q4 2020 | $10,144,000 | +28.8% | 357,922 | +14.2% | 0.00% | 0.0% |
| Q3 2020 | $7,877,000 | +15.5% | 313,304 | +12.1% | 0.00% | 0.0% |
| Q2 2020 | $6,822,000 | +76.1% | 279,371 | +6.7% | 0.00% | +100.0% |
| Q1 2020 | $3,875,000 | -27.2% | 261,858 | -20.1% | 0.00% | 0.0% |
| Q4 2019 | $5,320,000 | -61.9% | 327,864 | -69.5% | 0.00% | -75.0% |
| Q3 2019 | $13,971,000 | -52.2% | 1,074,706 | -52.3% | 0.00% | -50.0% |
| Q2 2019 | $29,233,000 | -19.1% | 2,253,797 | -1.7% | 0.01% | -20.0% |
| Q1 2019 | $36,135,000 | -29.4% | 2,292,785 | -9.8% | 0.01% | -37.5% |
| Q4 2018 | $51,175,000 | -16.4% | 2,542,242 | +3.1% | 0.02% | 0.0% |
| Q3 2018 | $61,245,000 | +14.7% | 2,464,617 | +26.7% | 0.02% | +6.7% |
| Q2 2018 | $53,381,000 | -13.9% | 1,944,679 | -3.4% | 0.02% | -11.8% |
| Q1 2018 | $62,007,000 | -19.1% | 2,013,232 | -6.1% | 0.02% | -15.0% |
| Q4 2017 | $76,672,000 | +38.5% | 2,144,669 | +6.7% | 0.02% | +33.3% |
| Q3 2017 | $55,356,000 | +0.8% | 2,009,313 | -3.4% | 0.02% | 0.0% |
| Q2 2017 | $54,901,000 | +45.2% | 2,079,562 | +14.4% | 0.02% | +50.0% |
| Q1 2017 | $37,810,000 | -5.9% | 1,817,798 | -6.4% | 0.01% | -16.7% |
| Q4 2016 | $40,194,000 | +28.9% | 1,941,730 | +1.0% | 0.01% | +33.3% |
| Q3 2016 | $31,175,000 | +8.2% | 1,923,108 | -9.2% | 0.01% | 0.0% |
| Q2 2016 | $28,812,000 | -16.1% | 2,118,558 | +7.8% | 0.01% | -10.0% |
| Q1 2016 | $34,329,000 | -50.0% | 1,966,175 | -2.2% | 0.01% | -52.4% |
| Q4 2015 | $68,647,000 | +20.7% | 2,009,567 | +5.1% | 0.02% | +23.5% |
| Q3 2015 | $56,887,000 | -3.3% | 1,911,487 | +3.9% | 0.02% | +6.2% |
| Q2 2015 | $58,848,000 | +143.8% | 1,840,141 | +58.0% | 0.02% | +166.7% |
| Q1 2015 | $24,136,000 | +39.2% | 1,164,294 | +13.8% | 0.01% | +20.0% |
| Q4 2014 | $17,337,000 | +968.2% | 1,023,422 | +1118.6% | 0.01% | – |
| Q3 2014 | $1,623,000 | -78.2% | 83,984 | -61.6% | 0.00% | -100.0% |
| Q2 2014 | $7,444,000 | +1192.4% | 218,854 | +1096.3% | 0.00% | – |
| Q1 2014 | $576,000 | – | 18,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |